cGxP.wire https://validator.w3.org/feed/docs/rss2.html Lilly Expands Indiana Manufacturing With $4.5B Persistent Launches AI Innovation Lab With IIT Kharagpur ALX Oncology Reports Durable HER2 Breast Cancer Data Mission Bio Unveils Single-Cell CRISPR T Cell Data Eisai and Biogen Receive FDA Extension for LEQEMBI TRexBio Reports New TRB-061 Data for Atopic Dermatitis Beacon Therapeutics Reports Positive XLRP Gene Therapy Data BioRestorative Therapies Reports Strong Phase 2 BRTX-100 Data Incyte Opzelura Shows Durable Atopic Dermatitis Benefit Bausch + Lomb Bi-Blade+ Boosts Retina Surgery Efficiency Glucotrack Announces FDA IDE Submission for Implantable Continuous Blood Glucose Monitoring Technology LiT Biosciences Launches LiT Protect Wellness Supplement Atsena Therapeutics Reports Positive Gene Therapy Data at ARVO 2026 Pierre Fabre Advances FDA Path for Tabelecleucel Opus Genetics Showcases IRD Gene Therapy Progress at ARVO 2026 KUBTEC Launches XCELL TomoRad IGRT Research System Aptar Pharma Advances FDA-Funded Next-Generation Inhaler Research Halozyme and Oruka Partner on Hypercon Biologics Deal Merck Publishes Science Paper on Scalable Oral PCSK9 Inhibitor Manufacturing Harbour BioMed Receives FDA IND Clearance for HBM7004 Solid Tumor Trial Rznomics Announces FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma CardiolRx Phase II Results Support Heart Disease Therapy ArteraAI Breast Gains FDA Clearance for Cancer Risk GSK Signs $1B SiranBio siRNA Cardiometabolic Deal Zelluna ASA Activates First Clinical Site for ZIMA-101 Phase 1 Solid Cancer Trial Waiv and Daiichi Sankyo Partner on AI Biomarkers Moderna Publishes Positive Phase 3 Clinical Data for mRNA-1010 Seasonal Influenza Vaccine in New England Journal of Medicine RIVANNA Gains FDA Clearance for Accuro XV AI System Totus Medicines Reports Strong Phase 1b Clinical Results for TOS-358 in HR+/HER2- Breast Cancer LTZ Therapeutics Raises $38M for Immunotherapy Pipeline Bayer PET Tracer Shows Promise in Amyloidosis Study BriaCell Gains FDA Clearance for Breast Cancer Trial Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence Gallant Advances Stem Cell Therapy for Canine OA Clear Scientific Gains FDA Fast Track for CS-1103 Diakonos Gains FDA Fast Track for DOC1021 Melanoma CARBOGEN AMCIS Passes Unannounced NMPA GMP Audit Revolution Medicines Publishes Daraxonrasib Pancreatic Cancer Data in NEJM Armata Gains FDA Fast Track for AP-SA02 Therapy Smith+Nephew Unveils New Chronic Wound Care Technologies Aurion Biotech Highlights AURN001 Cell Therapy at ASGCT 2026 Ribo and Boehringer Advance siRNA MASH Program Pharming Group Highlights Leniolisib Pediatric APDS Data at CIS 2026 HelioLiver Blood Test Shows Strong HCC Detection Roche to Acquire PathAI in $1.05 Billion AI Diagnostics Deal Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Rare Disease Expansion Deal Partner Therapeutics Gains FDA Priority Voucher for BIZENGRI® Edgewise Advances Muscle and Heart Disease Pipeline Oculis Holding AG Secures FDA SPA for Privosegtor Optic Neuritis Phase 3 Trial Drug Farm Reports DF-003 ROSAH Syndrome Data at ARVO